1. Home
  2. STTK vs TWIN Comparison

STTK vs TWIN Comparison

Compare STTK & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$6.07

Market Cap

538.3M

Sector

Health Care

ML Signal

HOLD

Logo Twin Disc Incorporated

TWIN

Twin Disc Incorporated

HOLD

Current Price

$16.63

Market Cap

269.7M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
TWIN
Founded
2016
1918
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
538.3M
269.7M
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
STTK
TWIN
Price
$6.07
$16.63
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
542.9K
65.5K
Earning Date
05-01-2026
05-06-2026
Dividend Yield
N/A
0.98%
EPS Growth
53.02
N/A
EPS
N/A
1.76
Revenue
$1,000,000.00
$340,738,000.00
Revenue This Year
N/A
$10.79
Revenue Next Year
N/A
$8.43
P/E Ratio
N/A
$9.09
Revenue Growth
N/A
15.45
52 Week Low
$0.71
$7.06
52 Week High
$8.33
$19.67

Technical Indicators

Market Signals
Indicator
STTK
TWIN
Relative Strength Index (RSI) 42.11 48.82
Support Level $5.85 $14.38
Resistance Level $6.81 $18.95
Average True Range (ATR) 0.45 1.24
MACD -0.09 -0.20
Stochastic Oscillator 21.66 39.27

Price Performance

Historical Comparison
STTK
TWIN

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About TWIN Twin Disc Incorporated

Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.

Share on Social Networks: